[The most important study results of primary chemoradiation for head and neck squamous cell carcinoma : highlights of the ASCO Meeting 2013].
Primary concomitant and sequential chemoradiation is a commonly used therapeutic strategy for head and neck squamous cell carcinoma. At the annual meeting of the American Society of Clinical Oncology 2013 numerous trial results were presented. A selection of the most important trials will be summarized in this article. This year several results from phase II and III trials in concomitant and sequential therapy were demonstrated.
Klinik und Poliklinik für Hals-, Nasen- und Ohrenheilkunde, Kopf-Hals-Tumorzentrum des Universitären Cancer Center Hamburg, Universitätsklinikum Hamburg-Eppendorf, Martinistr. 52, 20246, Hamburg-Eppendorf, Deutschland.
A
A
Münscher
C-J
CJ
Busch
P
P
Schafhausen
S
S
Tribius
R
R
Knecht
D002294:Carcinoma, Squamous Cell / Q000628:therapy*; D059248:Chemoradiotherapy / Q000379:methods*; D019317:Evidence-Based Medicine; D006258:Head and Neck Neoplasms / Q000628:therapy*; D006801:Humans; D000077195:Squamous Cell Carcinoma of Head and Neck; D016896:Treatment Outcome